Summary:A research team at Case Western Reserve University is pioneering a novel approach to multiple sclerosis (MS) treatment by targeting toxic astrocytes, with the goal of protecting and regenerating nerve cells. Key Takeaways: New Focus:Â The study targets toxic...
In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened between people receiving certain MS therapies and those not receiving treatment. The study is published in the September...
Women are three times more likely than men to get diagnosed with multiple sclerosis (MS), an incurable disease that affects the central nervous system. Now, rates of MS are on the rise among Black women. Research suggests that Black individuals may also be prone to...
More than 5 million people worldwide are living with neurodegenerative disorders like Parkinson’s disease and primary progressive multiple sclerosis (PPMS). Researchers funded by the National Stem Cell Foundation (NSCF) are turning to the microgravity environment of...
A Michigan Medicine-led study finds that stressors across the lifespan—including poverty, abuse, and divorce—are associated with worsening health and functional outcomes for people with multiple sclerosis, shown in multiple sclerosis flares. Using survey data from...
